Biological Medicines Evaluation And Research Unit (BMERU) Communication To Industry

Document NumberTitleCategoriesDate updatedVersionUnitsFile TypeLinkdoc_categories_hfilterdoc_tags_hfilter
9.126Reflection document on regulatory requirements for vaccines intended to provide protection against variant strain(s) of SARS-CoV-2

2021 May

1Downloadcommunication-to-industrybiological-medicines-evaluation-and-research
Submission of Post-Importation Testing Exemption requests for Biological and Biosimilar Medicines

2022 Mar

1, pdfDownloadcommunication-to-industrybiological-medicines-evaluation-and-research inspectorate-and-good-manufacturing-practices
Retention Fee Notification – 9 June 2022

2022 Jun

1, , , pdfDownloadcommunication-to-industrybiological-medicines-evaluation-and-research general-ectd-human-medicines-guidelines inspectorate-and-good-manufacturing-practices medical-devices
Communication on Medicines Registration Renewals Implementation Framework

2022 Nov

2, , , pdfDownloadcommunication-to-industrybiological-medicines-evaluation-and-research general-ectd-human-medicines-guidelines quality veterinary-medicines
Renewals Frequently Asked Questions (FAQs),

2022 Nov

1, , , pdfDownloadcommunication-to-industry faqbiological-medicines-evaluation-and-research general-ectd-human-medicines-guidelines quality veterinary-medicines